Table of Contents
ISRN Endocrinology
Volume 2012 (2012), Article ID 569862, 7 pages
http://dx.doi.org/10.5402/2012/569862
Clinical Study

Phenotype and Metabolic Disorders in Polycystic Ovary Syndrome

1The Medical Centre of Postgraduate Education, ul. Marymoncka 99/103, 01-813 Warsaw, Poland
2Department of Endocrinology CMKP, Bielański Hospital, ul. Cegłowska 80, 01–809 Warsaw, Poland

Received 23 October 2011; Accepted 8 December 2011

Academic Editors: A. Saxe and T.-H. Tung

Copyright © 2012 Olgierd Głuszak et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. I. F. Stein and M. L. Leventhal, “Amenorrhoea associated with bilalcnil polycystic ovaries,” American Journal of Obstetrics and Gynecology, vol. 29, pp. 181–191, 1935. View at Google Scholar
  2. M. O. Goodarzi and R. Azziz, “Diagnosis, epidemiology, and genetics of the polycystic ovary syndrome,” Best Practice and Research, vol. 20, no. 2, pp. 193–205, 2006. View at Publisher · View at Google Scholar
  3. M. I. Hsu, T. H. Liou, S. Y. Chou, C. Y. Chang, and C. S. Hsu, “Diagnostic criteria for polycystic ovary syndrome in Taiwanese Chinese women: comparison between Rotterdam 2003 and NIH 1990,” Fertility and Sterility, vol. 88, no. 3, pp. 727–729, 2007. View at Publisher · View at Google Scholar · View at Scopus
  4. Rotterdam ESHRE/ASRM-Sponsored PCOS Consensus Workshop Group, “Revised 2003 consensus on diagnostic criteria and long-term health risks related to polycystic ovary syndrome,” Fertility and Sterility, vol. 81, no. 1, pp. 19–25, 2004. View at Publisher · View at Google Scholar · View at Scopus
  5. W. Y. Chang, E. S. Knochenhauer, A. A. Bartolucci, and R. Azziz, “Phenotypic spectrum of polycystic ovary syndrome: clinical and biochemical characterization of the three major clinical subgroups,” Fertility and Sterility, vol. 83, no. 6, pp. 1717–1723, 2005. View at Publisher · View at Google Scholar · View at Scopus
  6. The Rotterdam ESHRE/ASRM-Sponsored PCOS Consensus Workshop Group, “Revised 2003 consensus on diagnostic criteria and long-term health risks related to polycystic ovary syndrome (PCOS),” Human Reproduction, vol. 19, pp. 41–74, 2004. View at Google Scholar
  7. H. Hassa, H. M. Tanir, and Z. Yildiz, “Comparison of clinical and laboratory characteristics of cases with polycystic ovarian syndrome based on Rotterdam's criteria and women whose only clinical signs are oligo/anovulation or hirsutism,” Archives of Gynecology and Obstetrics, vol. 274, no. 4, pp. 227–232, 2006. View at Publisher · View at Google Scholar · View at Scopus
  8. R. Azziz, “Controversy in clinical endocrinology: diagnosis of polycystic ovarian syndrome: the Rotterdam criteria are premature,” Journal of Clinical Endocrinology and Metabolism, vol. 91, no. 3, pp. 781–785, 2006. View at Publisher · View at Google Scholar
  9. D. Dewailly, S. Catteau-Jonard, A.-C. Reyss, M. Leroy, and P. Pigny, “Oligoanovulation with polycystic ovaries but not overt hyperandrogenism,” Journal of Clinical Endocrinology and Metabolism, vol. 91, no. 10, pp. 3922–3927, 2006. View at Publisher · View at Google Scholar
  10. C. K. Welt, J. A. Gudmundsson, G. Arason et al., “Characterizing discrete subsets of polycystic ovary syndrome as defined by the Rotterdam criteria: the impact of weight on phenotype and metabolic features,” Journal of Clinical Endocrinology and Metabolism, vol. 91, no. 12, pp. 4842–4848, 2006. View at Publisher · View at Google Scholar · View at Scopus
  11. B. Pehlivanov and M. Orbetzova, “Characteristics of different phenotypes of polycystic ovary syndrome in a Bulgarian population,” Gynecological Endocrinology, vol. 23, no. 10, pp. 604–609, 2007. View at Publisher · View at Google Scholar · View at Scopus